Cargando…

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer

Background: Triple negative breast cancer (TNBC), a fatal malignant tumor, is characterized by a lack of estrogen and progesterone hormone receptors and overexpression of HER2. Due to its characteristics, there are no effective targeted therapies for TNBC. Therefore, it is critical to identify the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Yuan, Chenwei, Peng, Jing, Zhou, Liheng, Jiang, Yiwei, Lin, Yanping, Yin, Wenjin, Xu, Shuguang, Ma, Jun, Lu, Jinsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423842/ https://www.ncbi.nlm.nih.gov/pubmed/32850368 http://dx.doi.org/10.3389/fonc.2020.01230

Ejemplares similares

Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer
por: Peng, Jing, et al.
Publicado: (2020)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
por: Wu, Ziping, et al.
Publicado: (2019)

SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans
por: Zhang, L, et al.
Publicado: (2016)

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
por: Lin, Yanping, et al.
Publicado: (2009)

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics
por: Peng, Jing, et al.
Publicado: (2017)

LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication
por: Sheng, Xiaonan, et al.
Publicado: (2021)

SHP-2-Induced Activation of c-Myc Is Involved in PDGF-B-Regulated Cell Proliferation and Angiogenesis in RMECs
por: Ma, Jun, et al.
Publicado: (2020)

The LDL Receptor-Related Protein 1 (LRP1) Regulates the PDGF Signaling Pathway by Binding the Protein Phosphatase SHP-2 and Modulating SHP-2- Mediated PDGF Signaling Events
por: Craig, Julie, et al.
Publicado: (2013)

Postoperative Fever: The Potential Relationship with Prognosis in Node Negative Breast Cancer Patients
por: Yan, Tingting, et al.
Publicado: (2010)

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
por: Amante, Romain J., et al.
Publicado: (2023)

Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
por: Sha, Rui, et al.
Publicado: (2021)

Long non‐coding RNA ZEB2‐AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple‐negative breast cancer by epigenetically activating ZEB2
por: Zhang, Guoxin, et al.
Publicado: (2019)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020)

Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy
por: Zhang, Shan, et al.
Publicado: (2020)

LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer
por: Xu, Yaqian, et al.
Publicado: (2021)

Upregulation Of miR-153 Inhibits Triple-Negative Breast Cancer Progression By Targeting ZEB2-Mediated EMT And Contributes To Better Prognosis
por: Shi, Dongliang, et al.
Publicado: (2019)

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study
por: Zhou, Liheng, et al.
Publicado: (2017)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

PDGF upregulates CLEC-2 to induce T regulatory cells
por: Agrawal, Sudhanshu, et al.
Publicado: (2015)

SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
por: Martin, Elisha, et al.
Publicado: (2021)

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors
Publicado: (1994)

Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials
por: Xu, Yaqian, et al.
Publicado: (2021)

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting
por: Wu, Ziping, et al.
Publicado: (2018)

Genome–wide binding of transcription factor ZEB1 in triple‐negative breast cancer cells
por: Maturi, Varun, et al.
Publicado: (2018)

PDGF and PDGF receptors in glioma
por: Nazarenko, Inga, et al.
Publicado: (2012)

The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2017)

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
por: Taylor, Julia, et al.
Publicado: (2023)

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis
por: Su, Jung-Chen, et al.
Publicado: (2016)

PDGF-Rα gene expression predicts proliferation, but PDGF-A suppresses transdifferentiation of neonatal mouse lung myofibroblasts
por: Kimani, Patricia W, et al.
Publicado: (2009)

Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients
por: Sun, Lu, et al.
Publicado: (2023)

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
por: Bayarmaa, Battseren, et al.
Publicado: (2019)

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
por: Song, Wei, et al.
Publicado: (2017)

DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1
por: Kim, Hye-Youn, et al.
Publicado: (2021)

ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer
por: Liu, Lingjia, et al.
Publicado: (2016)

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
por: Wang, Yaohui, et al.
Publicado: (2018)

First Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis
por: Jiang, Yiwei, et al.
Publicado: (2012)

GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple‐negative breast cancer via upregulation of Smad7
por: Zhou, Tian, et al.
Publicado: (2019)

A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
por: di Gennaro, Alessandra, et al.
Publicado: (2018)

SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer
por: Matalkah, Fatimah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_44hn9kfgeqpr6121ila86rcgl6